SLC6A4 and Huntington disease: Huntington’s disease patients exhibited moderately increased intra-platelet BDNF levels and significantly reduced cognitive/emotional abilities. However, platelet BDNF and serotonin (5-HT) transporter (SERT) did not specifically underlie psychosocial deficits in stage-II- Huntington’s disease.